AbbVie, Inc.
(NYSE : ABBV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.58%149.060.7%$734.24m
BMYBristol-Myers Squibb Co. -0.08%66.731.0%$726.64m
PFEPfizer Inc. -0.25%40.510.9%$611.72m
MRKMerck & Co., Inc. -0.22%90.980.7%$577.92m
ABBVAbbVie, Inc. -1.40%88.012.3%$545.73m
LLYEli Lilly & Co. -1.29%139.611.1%$400.65m
APLSApellis Pharmaceuticals, Inc. 0.30%40.500.0%$107.43m
NVSNovartis AG 0.88%95.940.2%$101.60m
AZNAstraZeneca Plc 1.62%51.331.2%$98.49m
GSKGlaxoSmithKline Plc 1.55%47.890.2%$84.36m
KRTXKaruna Therapeutics, Inc. 9.17%104.520.0%$68.78m
SNYSanofi 0.10%51.240.2%$68.67m
NVONovo Nordisk A/S -0.02%61.300.1%$64.41m
RETAReata Pharmaceuticals, Inc. -2.24%211.433.5%$64.03m
TPTXTurning Point Therapeutics, Inc. 2.72%59.950.0%$40.48m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.